Amplify Weight Loss Drug & Treatment ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. 

Index-Tracked
VettaFi Weight Loss Drug & Treat TR USD
Index-TrackedVettaFi Weight Loss Drug & Treat TR USD
Category
Health
CategoryHealth
Number of holdings
22
Number of holdings22
Inception Date
May 20, 2024
Inception DateMay 20, 2024

What's in this fund

Sectors

As of July 29, 2025
Healthcare95.55%
Consumer Defensive4.45%

Top 10 Holdings (67.88% of total assets)

As of July 28, 2025
NameSymbol% Assets
Eli LillyLLY12.22%
Novo NordiskNVO8.64%
RegeneronREGN7.40%
AmgenAMGN7.08%
Chugai Pharmaceutical Co Ltd4519 (XTKS)6.62%
Gilead SciencesGILD5.29%
MerckMRK5.25%
AbbVieABBV5.16%
AstraZenecaAZN5.13%
Innovent Biologics Inc01801 (XHKG)5.09%

THNR Key Statistics

AUM
2.99M
AUM2.99M
Price-Earnings ratio
24.83
Price-Earnings ratio24.83
30-Day yield
1.29
30-Day yield1.29
Average volume
3.21K
Average volume3.21K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$28.19
52 Week high$28.19
52 Week low
$18.56
52 Week low$18.56
Expense ratio
0.59
Expense ratio0.59
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.